series-b
Stage
4
Investors
About
Single Technologies develops a 3-D Sequencing platform that enables high-throughput spatial omics data capture directly in tissue and cells, aiming to serve as infrastructure for biological AI and advance precision medicine, cancer research, and virtual cell modeling.
Explore Single Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.